Imaging studies used to diagnose multiple myeloma may include: When a person is diagnosed with multiple myeloma, their healthcare team conducts additional tests to determine the cancer's stage.

Thousands of people are diagnosed each year with a type of blood cancer that often has no symptoms in its early stages. Myeloma, which affects approximately 24,000 people, is a disease that ...

Treating late stage myeloma has multiple challenges ... you know, be used to fight cancer in a way. And that can get a little bit harder with longer use of other therapies or late line use ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple myeloma ... later therapy for the blood cancer, and the KarMMa-3 study ...

Instead of disease-fighting antibodies, the cancer cells produce harmful proteins that don’t fight infection but instead damage your kidneys over time. In the early stages, multiple myeloma may ...

in adult patients with relapsed or refractory multiple myeloma. The trial demonstrated that Sarclisa SC, in combination with pomalidomide and dexamethasone (Pd), met its co-primary endpoints of ...